Gastrointestinal / GI Stent Market by Type (Biliary, Esophageal, Colonic, Pancreatic Stent) Material (Nitinol, Stainless Steel, Plastic) Disease (Biliary Disease, GI Cancer, IBD), End User (Hospital, Ambulatory Surgery Center) - Global Forecast to 2022

消化管/GIステントの世界市場予測(~2022年)

◆タイトル:Gastrointestinal / GI Stent Market by Type (Biliary, Esophageal, Colonic, Pancreatic Stent) Material (Nitinol, Stainless Steel, Plastic) Disease (Biliary Disease, GI Cancer, IBD), End User (Hospital, Ambulatory Surgery Center) - Global Forecast to 2022
◆商品コード:MAM-MD-5797
◆調査・発行会社:MarketsandMarkets
◆発行日:2017年12月7日
◆ページ数:184
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarketsが発行した当調査レポートでは、消化管/GIステントの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、種類別分析、材料別分析、疾患別分析、需要先別分析、消化管/GIステントの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“The gastrointestinal stents market is projected to grow at a CAGR of 5.1% between 2017 and 2022.”The gastrointestinal stents market is expected to reach USD 452.6 million by 2022 from USD 353.4 million in 2017, at a CAGR of 5.1% from 2017 to 2022. The rising prevalence of gastrointestinal cancers and other digestive diseases and the rising preference for minimally invasive procedures are some of the major factors driving the growth of this market. However, complications associated with gastrointestinal stent implementation are limiting the adoption of these stents.
“Pancreatic stents segment to witness the highest growth rate during the forecast period.”
On the basis of product, the pancreatic stents segment is expected to register the highest CAGR during the forecast period. The high growth of this segment is attributed to the growing number of endoscopic retrograde cholangiopancreatography procedures and the rising prevalence of acute pancreatitis.
“Self-expanding metal stents segment to grow at the highest CAGR from 2017 to 2022.”
Based on material, the self-expanding metal stents segment is expected to grow at the highest CAGR during the forecast period. The increasing adoption of these stents by hospitals and ASCs for the treatment of gastrointestinal diseases is the major factor supporting its growth during the forecast period.
“APAC to witness the highest growth rate during the forecast period.”
The Asia Pacific region is expected to witness the highest CAGR during the forecast period, owing to the rapidly developing healthcare industry in China and India, growth in aging population, rising life expectancy and per capita income, increasing investments in the region by key market players, the expansion of private-sector hospitals & clinics to rural areas, availability of low-cost labor, and presence of a favorable regulatory environment.
Break of primary participants:
• By Company Type – Tier 1: 46%, Tier 2–33%, and Tier 3–21%
• By Designation – C Level: 43%, Director Level: 35%, and Others: 22%
• By Region – North America: 28%, Europe: 34%, Asia Pacific: 22%, Latin America: 14%, and the Middle East & Africa: 6%
Research Coverage:
The report analyzes the various gastrointestinal stents and their adoption patterns in the market. It aims at estimating the market size and future growth potential of the global gastrointestinal stents market for different segments such as product, material, disease type, end user, and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater share. Firms purchasing the report could use any one or combination of the below-mentioned strategies for strengthening their market positions.
The report provides insights on the following pointers:
 Market Penetration: Comprehensive information on the product portfolios offered by the top players in the gastrointestinal stents market
 Product Development/Innovation: Detailed insights on research and development activities and new product launches in the gastrointestinal stents market
 Market Development: Comprehensive information about lucrative emerging markets, by product, material, disease type, end user, and region
 Market Diversification: Exhaustive information about new products, growing geographies, recent developments in the gastrointestinal stents market
 Competitive Assessment: In-depth assessment of growth strategies, products, and manufacturing capabilities of leading players in the gastrointestinal stents market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 18
1.1 OBJECTIVES OF THE STUDY 18
1.2 MARKET DEFINITION 18
1.3 MARKET SCOPE 19
1.3.1 MARKETS COVERED 19
1.3.2 YEARS CONSIDERED FOR THE STUDY 20
1.4 CURRENCY 20
1.5 LIMITATIONS 20
1.6 STAKEHOLDERS 20
2 RESEARCH METHODOLOGY 21
2.1 RESEARCH DATA 21
2.1.1 SECONDARY DATA 22
2.1.1.1 Key Data From Secondary Sources 22
2.1.2 PRIMARY DATA 23
2.1.2.1 Key data from primary sources 23
2.1.2.2 Breakdown of primary interviews: By company type, designations, and region 24
2.1.2.3 Key industry insights 24
2.2 MARKET SIZE ESTIMATION 25
2.2.1 BOTTOM-UP APPROACH 25
2.2.2 TOP-DOWN APPROACH 26
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 27
2.4 MARKET SHARE ESTIMATION 28
2.5 ASSUMPTIONS FOR THE STUDY 28
3 EXECUTIVE SUMMARY 29
4 PREMIUM INSIGHTS 33
4.1 GASTROINTESTINAL STENTS: MARKET OVERVIEW 33
4.2 ASIA PACIFIC: GASTROINTESTINAL CANCER STENTS MARKET, BY PRODUCT AND COUNTRY 34
4.3 GASTROINTESTINAL STENTS MARKET, BY COUNTRY 35
4.4 GASTROINTESTINAL STENTS MARKET, BY DISEASE TYPE 36
4.5 REGIONAL MIX: GASTROINTESTINAL STENTS MARKET 36

5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
5.2.1 DRIVERS 38
5.2.1.1 Rising prevalence of gastrointestinal cancers and other digestive diseases 38
5.2.1.2 Increasing geriatric population 39
5.2.1.3 Growing preference for minimally invasive procedures 40
5.2.1.4 Changing lifestyles 41
5.2.2 RESTRAINT 42
5.2.2.1 Complications associated with gastrointestinal stent implementation 42
5.2.3 OPPORTUNITIES 43
5.2.3.1 Development of biodegradable and drug-eluting gastrointestinal stents 43
5.2.3.2 Emerging markets 43
5.3 REIMBURSEMENT SCENARIO IN THE US 45
5.4 REGULATORY ANALYSIS 45
6 GASTROINTESTINAL STENTS MARKET, BY PRODUCT 50
6.1 INTRODUCTION 51
6.2 BILIARY STENTS 52
6.3 COLONIC STENTS 54
6.4 DUODENAL STENTS 55
6.5 PANCREATIC STENTS 57
6.6 ESOPHAGEAL STENTS 58
7 GASTROINTESTINAL STENTS MARKET, BY MATERIAL 60
7.1 INTRODUCTION 61
7.2 SELF-EXPANDING METAL STENTS 62
7.2.1 NITINOL STENTS 64
7.2.2 STAINLESS STEEL STENTS 65
7.2.3 OTHER METAL STENTS 66
7.3 PLASTIC STENTS 67
8 GASTROINTESTINAL STENTS MARKET, BY DISEASE TYPE 69
8.1 INTRODUCTION 70
8.2 BILIARY DISEASES 71
8.3 GASTROINTESTINAL CANCER 72
8.3.1 COLORECTAL CANCER 73
8.3.2 PANCREATIC CANCER 74

8.3.3 STOMACH CANCER 75
8.3.4 ESOPHAGEAL CANCER 76
8.4 INFLAMMATORY BOWEL DISEASES 77
9 GASTROINTESTINAL STENTS MARKET, BY END USER 79
9.1 INTRODUCTION 80
9.2 HOSPITALS 81
9.3 AMBULATORY SURGERY CENTERS 82
10 GASTROINTESTINAL STENTS MARKET, BY REGION 84
10.1 INTRODUCTION 85
10.2 NORTH AMERICA 86
10.2.1 US 90
10.2.2 CANADA 93
10.3 EUROPE 97
10.3.1 GERMANY 101
10.3.2 FRANCE 104
10.3.3 UK 107
10.3.4 ITALY 110
10.3.5 SPAIN 113
10.3.6 REST OF EUROPE 116
10.4 ASIA PACIFIC 119
10.4.1 CHINA 122
10.4.2 JAPAN 125
10.4.3 INDIA 128
10.4.4 REST OF ASIA PACIFIC 131
10.5 LATIN AMERICA 134
10.6 MIDDLE EAST & AFRICA 137
11 COMPETITIVE LANDSCAPE 141
11.1 OVERVIEW 141
11.2 MARKET RANKING 142
11.3 COMPETITIVE SCENARIO 144
11.4 DEVELOPMENTS 144
11.4.1 ACQUISITIONS 144
11.4.2 OTHER DEVELOPMENTS: PRODUCT LAUNCH AND EXPANSION 145
11.5 GASTROINTESTINAL STENTS MARKET: PRODUCT PORTFOLIO ANALYSIS 145

12 COMPANY PROFILES 146
(Business Overview, Products Offered, Swot Anlysis, MnM View.)*
12.1 BOSTON SCIENTIFIC 146
12.2 COOK GROUP 149
12.3 MICRO-TECH (NANJING) 151
12.4 TAEWOONG MEDICAL 153
12.5 ELLA–CS 155
12.6 C.R. BARD 157
12.7 BECTON, DICKINSON AND COMPANY 159
12.8 MERIT MEDICAL SYSTEMS 161
12.9 CONMED 163
12.10 CANTEL MEDICAL 165
12.11 OLYMPUS 167
12.12 ENDO-FLEX 169
12.13 M.I. TECH 170
12.14 DIAGMED HEALTHCARE 171
*Business Overview, Products Offered, Swot Anlysis, MnM View might not be captured in case of unlisted companies.
13 APPENDIX 172
13.1 INSIGHTS OF INDUSTRY EXPERTS 172
13.2 DISCUSSION GUIDE 173
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 177
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 179
13.5 AVAILABLE CUSTOMIZATIONS 180
13.6 RELATED REPORTS 181
13.7 AUTHOR DETAILS 182

LIST OF TABLES

TABLE 1 INCIDENCE OF COLORECTAL CANCER WORLDWIDE, 2012 38
TABLE 2 GLOBAL GASTROINTESTINAL CANCER INCIDENCE, 2012 38
TABLE 3 IMPACT ANALYSIS: DRIVERS 42
TABLE 4 FREQUENCY OF MOST COMMON STENT-RELATED COMPLICATIONS 42
TABLE 5 IMPACT ANALYSIS : RESTRAINT 43
TABLE 6 ESTIMATED INCIDENCE AND MORTALITY IN ASIA, BY CANCER TYPE, 2012 44
TABLE 7 INCIDENCE AND DEATHS CAUSED DUE TO STOMACH CANCER, BY COUNTRY, 2012 44
TABLE 8 IMPACT ANALYSIS : OPPORTUNITIES 44
TABLE 9 HOSPITAL OUTPATIENT AND ASC REIMBURSEMENT (USD) 45
TABLE 10 CLASSIFICATION OF MEDICAL DEVICES AND THE REVIEWING BODY IN JAPAN 48
TABLE 11 GLOBAL GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 51
TABLE 12 GLOBAL GASTROINTESTINAL STENTS MARKET, BY COUNTRY/REGION,
2015–2022 (USD MILLION) 52
TABLE 13 BILIARY STENTS: KEY PRODUCTS OFFERED BY PROMINENT PLAYERS 53
TABLE 14 GLOBAL BILIARY STENTS MARKET, BY COUNTRY/REGION,
2015–2022 (USD MILLION) 53
TABLE 15 COLONIC STENTS: KEY PRODUCTS OFFERED BY PROMINENT PLAYERS 54
TABLE 16 GLOBAL COLONIC STENTS MARKET, BY COUNTRY/REGION,
2015–2022 (USD MILLION) 55
TABLE 17 DUODENAL STENTS: KEY PRODUCTS OFFERED BY PROMINENT PLAYERS 56
TABLE 18 GLOBAL DUODENAL STENTS MARKET, BY COUNTRY/REGION,
2015–2022 (USD MILLION) 56
TABLE 19 PANCREATIC STENTS: KEY PRODUCTS OFFERED BY PROMINENT PLAYERS 57
TABLE 20 GLOBAL PANCREATIC STENTS MARKET, BY COUNTRY/REGION,
2015–2022 (USD MILLION) 58
TABLE 21 ESOPHAGEAL STENTS: KEY PRODUCTS OFFERED BY PROMINENT PLAYERS 59
TABLE 22 GLOBAL ESOPHAGEAL STENTS MARKET, BY COUNTRY/REGION,
2015–2022 (USD MILLION) 59
TABLE 23 GLOBAL GASTROINTESTINAL STENTS MARKET, BY MATERIAL,
2015–2022 (USD MILLION) 61
TABLE 24 SELF-EXPANDING METAL STENTS: KEY PRODUCTS OFFERED BY THE PROMINENT PLAYERS 62
TABLE 25 GLOBAL SELF-EXPANDING METAL STENTS MARKET, BY TYPE,
2015–2022 (USD MILLION) 63
TABLE 26 GLOBAL GASTROINTESTINAL SELF-EXPANDING METAL STENTS MARKET,
BY COUNTRY/REGION, 2015–2022 (USD MILLION) 63
TABLE 27 GLOBAL NITINOL STENTS MARKET, BY COUNTRY/REGION,
2015–2022 (USD MILLION) 64
TABLE 28 GLOBAL STAINLESS STEEL STENTS MARKET, BY COUNTRY/REGION,
2015–2022 (USD MILLION) 65
TABLE 29 GLOBAL OTHER METAL STENTS MARKET, BY COUNTRY/REGION,
2015–2022 (USD MILLION) 66
TABLE 30 PLASTIC STENTS: KEY PRODUCTS OFFERED BY PROMINENT PLAYERS 67
TABLE 31 GLOBAL PLASTIC STENTS MARKET, BY COUNTRY/REGION,
2015–2022 (USD MILLION) 68
TABLE 32 GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY DISEASE TYPE,
2015–2022 (USD MILLION) 70
TABLE 33 GLOBAL BILIARY DISEASES STENTS MARKET, BY COUNTRY/REGION,
2015–2022 (USD MILLION) 71
TABLE 34 GLOBAL GASTROINTESTINAL CANCER STENTS MARKET, BY TYPE,
2015–2022 (USD MILLION) 72
TABLE 35 GLOBAL GASTROINTESTINAL CANCER STENTS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION) 73
TABLE 36 GLOBAL COLORECTAL CANCER STENTS MARKET, BY COUNTRY/REGION,
2015–2022 (USD MILLION) 74
TABLE 37 GLOBAL PANCREATIC CANCER STENTS MARKET, BY COUNTRY/REGION,
2015–2022 (USD MILLION) 75
TABLE 38 GLOBAL STOMACH CANCER STENTS MARKET, BY COUNTRY/REGION,
2015–2022 (USD MILLION) 76
TABLE 39 GLOBAL ESOPHAGEAL CANCER STENTS MARKET, BY COUNTRY/REGION,
2015–2022 (USD MILLION) 77
TABLE 40 GLOBAL INFLAMMATORY BOWEL DISEASES STENTS MARKET,
BY COUNTRY/REGION, 2015–2022 (USD MILLION) 78
TABLE 41 GLOBAL GASTROINTESTINAL STENTS MARKET, BY END USER,
2015–2022 (USD MILLION) 80
TABLE 42 REIMBURSEMENT IN HOSPITAL OUTPATIENTS FOR ERCP STENTING
PROCEDURES (USD) 81
TABLE 43 GLOBAL HOSPITALS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION) 82
TABLE 44 NUMBER OF MEDICARE-CERTIFIED ASCS IN THE US (2009–2014) 83
TABLE 45 REIMBURSEMENT IN ASC FOR ERCP STENTING PROCEDURES (USD) 83
TABLE 46 GLOBAL AMBULATORY SURGERY CENTERS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION) 83
TABLE 47 NORTH AMERICA: GI CANCER INCIDENCE IN THE GERIATRIC POPULATION,
(2012 VS 2030) 86
TABLE 48 NORTH AMERICA: GASTROINTESTINAL STENTS MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 88
TABLE 49 NORTH AMERICA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 88
TABLE 50 NORTH AMERICA: GASTROINTESTINAL STENTS MARKET, BY MATERIAL,
2015–2022 (USD MILLION) 88
TABLE 51 NORTH AMERICA: GASTROINTESTINAL SELF-EXPANDING METAL STENTS MARKET, BY TYPE, 2015–2022 (USD MILLION) 89
TABLE 52 NORTH AMERICA: GASTROINTESTINAL STENTS MARKET, BY DISEASE,
2015–2022 (USD MILLION) 89
TABLE 53 NORTH AMERICA: GASTROINTESTINAL CANCER STENTS MARKET, BY TYPE,
2015–2022 (USD MILLION) 90
TABLE 54 NORTH AMERICA: GASTROINTESTINAL STENTS MARKET, BY END USER,
2015–2022 (USD MILLION) 90
TABLE 55 US: ESTIMATED CASES OF DIGESTIVE SYSTEM CANCER, BY TYPE (2017) 91
TABLE 56 US: MACROECONOMIC INDICATORS 91
TABLE 57 US: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 91
TABLE 58 US: GASTROINTESTINAL STENTS MARKET, BY MATERIAL,
2015–2022 (USD MILLION) 92
TABLE 59 US: GASTROINTESTINAL SELF-EXPANDING METAL STENTS MARKET, BY TYPE, 2015–2022 (USD MILLION) 92
TABLE 60 US: GASTROINTESTINAL STENTS MARKET, BY DISEASE,
2015–2022 (USD MILLION) 92
TABLE 61 US: GASTROINTESTINAL CANCER STENTS MARKET, BT TYPE,
2015–2022 (USD MILLION) 93
TABLE 62 US: GASTROINTESTINAL STENTS MARKET, BY END USER,
2015–2022 (USD MILLION) 93
TABLE 63 CANADA: ESTIMATED CASES OF DIGESTIVE SYSTEM CANCER, BY TYPE (2017) 94
TABLE 64 CANADA: MACROECONOMIC INDICATORS 94
TABLE 65 CANADA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 94
TABLE 66 CANADA.: GASTROINTESTINAL STENTS MARKET, BY MATERIAL,
2015–2022 (USD MILLION) 95
TABLE 67 CANADA: GASTROINTESTINAL SELF-EXPANDING METAL STENTS MARKET,
BY TYPE, 2015–2022 (USD MILLION) 95
TABLE 68 CANADA: GASTROINTESTINAL STENTS MARKET, BY DISEASE,
2015–2022 (USD MILLION) 95
TABLE 69 CANADA: GASTROINTESTINAL CANCER STENTS MARKET, BY TYPE,
2015–2022 (USD MILLION) 96
TABLE 70 CANADA: GASTROINTESTINAL STENTS MARKET, BY END USER,
2015–2022 (USD MILLION) 96
TABLE 71 EUROPE: GASTROINTESTINAL CANCER INCIDENCE AMONG GERIATRIC POPULATION, BY TYPE (2012 VS 2030) 97
TABLE 72 EUROPE: GASTROINTESTINAL STENTS MARKET, BY COUNTRY/REGION,
2015–2022 (USD MILLION) 99
TABLE 73 EUROPE: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 99
TABLE 74 EUROPE: GASTROINTESTINAL STENTS MARKET, BY MATERIAL,
2015–2022 (USD MILLION) 100
TABLE 75 EUROPE: GASTROINTESTINAL SELF-EXPANDING METAL STENTS MARKET,
BY TYPE, 2015–2022 (USD MILLION) 100
TABLE 76 EUROPE: GASTROINTESTINAL STENTS MARKET, BY DISEASE,
2015–2022 (USD MILLION) 100
TABLE 77 EUROPE: GASTROINTESTINAL CANCER STENTS MARKET, BT TYPE,
2015–2022 (USD MILLION) 101
TABLE 78 EUROPE: GASTROINTESTINAL STENTS MARKET, BY END USER,
2015–2022 (USD MILLION) 101
TABLE 79 GERMANY: MACROECONOMIC INDICATORS 102
TABLE 80 GERMANY: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 102
TABLE 81 GERMANY: GASTROINTESTINAL STENTS MARKET, BY MATERIAL,
2015–2022 (USD MILLION) 103
TABLE 82 GERMANY: GASTROINTESTINAL SELF-EXPANDING METAL STENTS MARKET,
BY TYPE, 2015–2022 (USD MILLION) 103
TABLE 83 GERMANY: GASTROINTESTINAL STENTS MARKET, BY DISEASE,
2015–2022 (USD MILLION) 103
TABLE 84 GERMANY: GASTROINTESTINAL CANCER STENTS MARKET, BT TYPE,
2015–2022 (USD MILLION) 104
TABLE 85 GERMANY: GASTROINTESTINAL STENTS MARKET, BY END USER,
2015–2022 (USD MILLION) 104
TABLE 86 FRANCE: GI CANCER INCIDENCE AMONG GERIATRIC POPULATION, BY TYPE
(2012 VS 2030) 105
TABLE 87 FRANCE: MACROECONOMIC INDICATORS 105
TABLE 88 FRANCE: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 105
TABLE 89 FRANCE: GASTROINTESTINAL STENTS MARKET, BY MATERIAL,
2015–2022 (USD MILLION) 106
TABLE 90 FRANCE: GASTROINTESTINAL SELF-EXPANDING METAL STENTS MARKET,
BY TYPE, 2015–2022 (USD MILLION) 106
TABLE 91 FRANCE: GASTROINTESTINAL STENTS MARKET, BY DISEASE,
2015–2022 (USD MILLION) 106
TABLE 92 FRANCE: GASTROINTESTINAL CANCER STENTS MARKET,
BT TYPE, 2015–2022 (USD MILLION) 107
TABLE 93 FRANCE: GASTROINTESTINAL STENTS MARKET, BY END USER,
2015–2022 (USD MILLION) 107
TABLE 94 UK: GASTROINTESTINAL CANCER INCIDENCEAMONG GERIATRIC POPULATION,
BY TYPE (2012 VS 2030) 108
TABLE 95 UK: MACROECONOMIC INDICATORS 108
TABLE 96 UK: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 108
TABLE 97 UK: GASTROINTESTINAL STENTS MARKET, BY MATERIAL,
2015–2022 (USD MILLION) 109
TABLE 98 UK: GASTROINTESTINAL SELF-EXPANDING METAL STENTS MARKET,
BY TYPE, 2015–2022 (USD MILLION) 109
TABLE 99 UK: GASTROINTESTINAL STENTS MARKET, BY DISEASE,
2015–2022 (USD MILLION) 109
TABLE 100 UK: GASTROINTESTINAL CANCER STENTS MARKET, BT TYPE,
2015–2022 (USD MILLION) 110
TABLE 101 UK: GASTROINTESTINAL STENTS MARKET, BY END USER,
2015–2022 (USD MILLION) 110
TABLE 102 ITALY: GASTROINTESTINAL CANCER INCIDENCE AMONG GERIATRIC POPULATION, BY TYPE (2012 VS 2030) 111
TABLE 103 ITALY: MACROECONOMIC INDICATORS 111
TABLE 104 ITALY: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 111
TABLE 105 ITALY: GASTROINTESTINAL STENTS MARKET, BY MATERIAL,
2015–2022 (USD MILLION) 112
TABLE 106 ITALY: GASTROINTESTINAL SELF-EXPANDING METAL STENTS MARKET, BY TYPE, 2015–2022 (USD MILLION) 112
TABLE 107 ITALY: GASTROINTESTINAL STENTS MARKET, BY DISEASE,
2015–2022 (USD MILLION) 112
TABLE 108 ITALY: GASTROINTESTINAL CANCER STENTS MARKET, BT TYPE,
2015–2022 (USD MILLION) 113
TABLE 109 ITALY: GASTROINTESTINAL STENTS MARKET, BY END USER,
2015–2022 (USD MILLION) 113
TABLE 110 SPAIN: GI CANCER INCIDENCE AMONG GERIATRIC POPULATION,
BY TYPE (2012 VS 2030) 114
TABLE 111 SPAIN: MACROECONOMIC INDICATORS 114
TABLE 112 SPAIN: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 114
TABLE 113 SPAIN: GASTROINTESTINAL STENTS MARKET, BY MATERIAL,
2015–2022 (USD MILLION) 115
TABLE 114 SPAIN: GASTROINTESTINAL SELF-EXPANDING METAL STENTS MARKET,
BY TYPE, 2015–2022 (USD MILLION) 115
TABLE 115 SPAIN: GASTROINTESTINAL STENTS MARKET, BY DISEASE,
2015–2022 (USD MILLION) 115
TABLE 116 SPAIN: GASTROINTESTINAL CANCER STENTS MARKET, BT TYPE,
2015–2022 (USD MILLION) 116
TABLE 117 SPAIN: GASTROINTESTINAL STENTS MARKET, BY END USER,
2015–2022 (USD MILLION) 116
TABLE 118 ROE: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 117
TABLE 119 ROE: GASTROINTESTINAL STENTS MARKET, BY MATERIAL,
2015–2022 (USD MILLION) 117
TABLE 120 ROE: GASTROINTESTINAL SELF-EXPANDING METAL STENTS MARKET,
BY TYPE, 2015–2022 (USD MILLION) 118
TABLE 121 ROE: GASTROINTESTINAL STENTS MARKET, BY DISEASE,
2015–2022 (USD MILLION) 118
TABLE 122 ROE: GASTROINTESTINAL CANCER STENTS MARKET, BT TYPE,
2015–2022 (USD MILLION) 118
TABLE 123 ROE: GASTROINTESTINAL STENTS MARKET, BY END USER,
2015–2022 (USD MILLION) 119
TABLE 124 ASIA PACIFIC: GI CANCER INCIDENCE AND MORTALITY RATE, BY TYPE, (2012) 119
TABLE 125 ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY COUNTRY/REGION,
2015–2022 (USD MILLION) 120
TABLE 126 ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 120
TABLE 127 ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY MATERIAL,
2015–2022 (USD MILLION) 121
TABLE 128 ASIA PACIFIC: GASTROINTESTINAL SELF-EXPANDING METAL STENTS MARKET,
BY TYPE, 2015–2022 (USD MILLION) 121
TABLE 129 ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY DISEASE,
2015–2022 (USD MILLION) 121
TABLE 130 ASIA PACIFIC: GASTROINTESTINAL CANCER STENTS MARKET, BT TYPE,
2015–2022 (USD MILLION) 122
TABLE 131 ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY END USER,
2015–2022 (USD MILLION) 122
TABLE 132 CHINA: GI CANCER INCIDENCE AMONG GERIATRIC POPULATION, BY TYPE,
(2012 VS 2030) 123
TABLE 133 CHINA: MACROECONOMIC INDICATORS 123
TABLE 134 CHINA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 123
TABLE 135 CHINA: GASTROINTESTINAL STENTS MARKET, BY MATERIAL,
2015–2022 (USD MILLION) 124
TABLE 136 CHINA: GASTROINTESTINAL SELF-EXPANDING METAL STENTS MARKET,
BY TYPE, 2015–2022 (USD MILLION) 124
TABLE 137 CHINA: GASTROINTESTINAL STENTS MARKET, BY DISEASE,
2015–2022 (USD MILLION) 124
TABLE 138 CHINA: GASTROINTESTINAL CANCER STENTS MARKET, BT TYPE,
2015–2022 (USD MILLION) 125
TABLE 139 CHINA: GASTROINTESTINAL STENTS MARKET, BY END USER,
2015–2022 (USD MILLION) 125
TABLE 140 JAPAN: GI CANCER INCIDENCE AMONG GERIATRIC POPULATION, BY TYPE,
(2012 VS 2030) 126
TABLE 141 JAPAN: MACROECONOMIC INDICATORS 126
TABLE 142 JAPAN: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 126
TABLE 143 JAPAN: GASTROINTESTINAL STENTS MARKET, BY MATERIAL,
2015–2022 (USD MILLION) 127
TABLE 144 JAPAN: GASTROINTESTINAL SELF-EXPANDING METAL STENTS MARKET,
BY TYPE, 2015–2022 (USD MILLION) 127
TABLE 145 JAPAN: GASTROINTESTINAL STENTS MARKET, BY DISEASE,
2015–2022 (USD MILLION) 127
TABLE 146 JAPAN: GASTROINTESTINAL CANCER STENTS MARKET, BT TYPE,
2015–2022 (USD MILLION) 128
TABLE 147 JAPAN: GASTROINTESTINAL STENTS MARKET, BY END USER,
2015–2022 (USD MILLION) 128
TABLE 148 INDIA: GASTROINTESTINAL CANCER INCIDENCE, BY TYPE (2012 VS 2030) 129
TABLE 149 INDIA: MACROECONOMIC INDICATORS 129
TABLE 150 INDIA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 129
TABLE 151 INDIA: GASTROINTESTINAL STENTS MARKET, BY MATERIAL,
2015–2022 (USD MILLION) 130
TABLE 152 INDIA: GASTROINTESTINAL SELF-EXPANDING METAL STENTS MARKET, BY TYPE, 2015–2022 (USD MILLION) 130
TABLE 153 INDIA: GASTROINTESTINAL STENTS MARKET, BY DISEASE,
2015–2022 (USD MILLION) 130
TABLE 154 INDIA: GASTROINTESTINAL CANCER STENTS MARKET, BY TYPE,
2015–2022 (USD MILLION) 131
TABLE 155 INDIA: GASTROINTESTINAL STENTS MARKET, BY END USER,
2015–2022 (USD MILLION) 131
TABLE 156 ROAPAC: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 132
TABLE 157 ROAPAC: GASTROINTESTINAL STENTS MARKET, BY MATERIAL,
2015–2022 (USD MILLION) 132
TABLE 158 ROAPAC: GASTROINTESTINAL SELF-EXPANDING METAL STENTS MARKET, BY TYPE, 2015–2022 (USD MILLION) 133
TABLE 159 ROAPAC: GASTROINTESTINAL STENTS MARKET, BY DISEASE,
2015–2022 (USD MILLION) 133
TABLE 160 ROAPAC: GASTROINTESTINAL CANCER STENTS MARKET, BY TYPE,
2015–2022 (USD MILLION) 134
TABLE 161 ROAPAC: GASTROINTESTINAL STENTS MARKET, BY END USER,
2015–2022 (USD MILLION) 134
TABLE 162 LATIN AMERICA: GASTROINTESTINAL CANCER INCIDENCE, BY TYPE, 2012 VS 2030 135
TABLE 163 LATIN AMERICA: MACROECONOMIC INDICATORS 135
TABLE 164 LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 135
TABLE 165 LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY MATERIAL,
2015–2022 (USD MILLION) 136
TABLE 166 LATIN AMERICA: GASTROINTESTINAL SELF-EXPANDING METAL STENTS MARKET, BY TYPE, 2015–2022 (USD MILLION) 136
TABLE 167 LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY DISEASE,
2015–2022 (USD MILLION) 136
TABLE 168 LATIN AMERICA: GASTROINTESTINAL CANCER STENTS MARKET, BT TYPE,
2015–2022 (USD MILLION) 137
TABLE 169 LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY END USER,
2015–2022 (USD MILLION) 137
TABLE 170 MIDDLE EAST & AFRICA: GI CANCER INCIDENCE, BY TYPE,2012 VS 2030 137
TABLE 171 MIDDLE EAST AND AFRICA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 138
TABLE 172 MIDDLE EAST AND AFRICA: GASTROINTESTINAL STENTS MARKET, BY MATERIAL, 2015–2022 (USD MILLION) 138
TABLE 173 MIDDLE EAST AND AFRICA: GASTROINTESTINAL SELF-EXPANDING METAL STENTS MARKET, BY TYPE, 2015–2022 (USD MILLION) 139
TABLE 174 MIDDLE EAST AND AFRICA: GASTROINTESTINAL STENTS MARKET, BY DISEASE, 2015–2022 (USD MILLION) 139
TABLE 175 MIDDLE EAST AND AFRICA: GASTROINTESTINAL CANCER STENTS MARKET,
BT TYPE, 2015–2022 (USD MILLION) 139
TABLE 176 MIDDLE EAST AND AFRICA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2015–2022 (USD MILLION) 140
TABLE 177 MARKET RANKING OF THE KEY PLAYERS IN GASTROINTESTINAL
STENTS MARKET, 2016 142


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 21
FIGURE 2 DATA TRIANGULATION METHODOLOGY 27
FIGURE 3 GLOBAL GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2017 VS. 2022 (USD MILLION) 29
FIGURE 4 GLOBAL GASTROINTESTINAL STENTS MARKET, BY MATERIAL,
2017 VS. 2022 (USD MILLION) 30
FIGURE 5 GLOBAL GASTROINTESTINAL STENTS MARKET, BY DISEASE TYPE,
2017 VS. 2022 (USD MILLION) 30
FIGURE 6 GLOBAL GASTROINTESTINAL STENTS MARKET, BY END USER,
2017 VS. 2022 (USD MILLION) 31
FIGURE 7 GEOGRAPHICAL SNAPSHOT OF THE GLOBAL GASTROINTESTINAL STENTS MARKET 32
FIGURE 8 RISING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES IS PROPELLING GROWTH IN THE GASTROINTESTINAL STENTS MARKET 33
FIGURE 9 COLORECTAL CANCER SEGMENT COMMANDED THE LARGEST SHARE OF THE GASTROINTESTINAL CANCER STENTS MARKET IN 2016 34
FIGURE 10 US ACCOUNTED FOR THE LARGEST SHARE OF THE GASTROINTESTINAL STENTS MARKET IN 2016 35
FIGURE 11 BILIARY DISEASES SEGMENT WILL CONTINUE TO DOMINATE THE GASTROINTESTINAL STENTS MARKET BY 2022 36
FIGURE 12 ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH RATE IN THE GASTROINTESTINAL STENTS MARKET DURING THE FORECAST PERIOD 36
FIGURE 13 GASTROINTESTINAL STENTS MARKET: DRIVERS, OPPORTUNITIES, & CHALLENGES 37
FIGURE 14 GLOBAL GERIATRIC POPULATION, BY REGION, 2010 VS. 2015 VS. 2030 39
FIGURE 15 GLOBAL GERIATRIC POPULATION, BY COUNTRY, 2000 VS. 2015 40
FIGURE 16 OVERWEIGHT ADULT POPULATION, BY COUNTRY, 2010 VS 2014 (% OF TOTAL ADULT POPULATION) 41
FIGURE 17 CE APPROVAL PROCESS FOR GASTROINTESTINAL STENTS 47
FIGURE 18 BILIARY SEGMENT WILL CONTINUE TO DOMINATE THE GLOBAL GASTROINTESTINAL STENTS MARKET BY 2022 51
FIGURE 19 SELF-EXPANDING METAL STENTS SEGMENT WILL CONTINUE TO DOMINATE THE GLOBAL GASTROINTESTINAL STENTS MARKET BY 2022 61
FIGURE 20 BILIARY DISEASES TO DOMINATE GASTROINTESTINAL STENTS MARKET,
BY DISEASE TYPE IN 2017 70
FIGURE 21 HOSPITALS SEGMENT WILL CONTINUE TO DOMINATE THE GLOBAL GASTROINTESTINAL STENTS MARKET BY 2022 80
FIGURE 22 GASTROINTESTINAL STENTS MARKET: GEOGRAPHIC SNAPSHOT 85
FIGURE 23 NORTH AMERICA: GASTROINTESTINAL STENTS MARKET SNAPSHOT 87
FIGURE 24 EUROPE: GASTROINTESTINAL STENTS MARKET SNAPSHOT 98
FIGURE 25 KEY DEVELOPMENTS IN THE GASTROINTESTINAL STENTS MARKET, 2014–2017 141
FIGURE 26 BOSTON SCIENTIFIC: COMPANY SNAPSHOT 146
FIGURE 27 C.R. BARD: COMPANY SNAPSHOT 157
FIGURE 28 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT 159
FIGURE 29 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT 161

FIGURE 30 CONMED: COMPANY SNAPSHOT 163
FIGURE 31 CANTEL MEDICAL: COMPANY SNAPSHOT (2017) 165
FIGURE 32 OLYMPUS: COMPANY SNAPSHOT 167


【レポートのキーワード】

消化管ステント、GIステント、ステント素材、医療機器、疾患、胆道疾患、GI癌、IBD、病院、治療

★調査レポート[消化管/GIステントの世界市場予測(~2022年)] ( Gastrointestinal / GI Stent Market by Type (Biliary, Esophageal, Colonic, Pancreatic Stent) Material (Nitinol, Stainless Steel, Plastic) Disease (Biliary Disease, GI Cancer, IBD), End User (Hospital, Ambulatory Surgery Center) - Global Forecast to 2022 / MAM-MD-5797) 販売に関する免責事項
[消化管/GIステントの世界市場予測(~2022年)] ( Gastrointestinal / GI Stent Market by Type (Biliary, Esophageal, Colonic, Pancreatic Stent) Material (Nitinol, Stainless Steel, Plastic) Disease (Biliary Disease, GI Cancer, IBD), End User (Hospital, Ambulatory Surgery Center) - Global Forecast to 2022 / MAM-MD-5797) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆